SCYNEXIS, Inc. (SCYX) Wins BARDA Contract Worth Up To $214M

SCYNEXIS was awarded a BARDA contract providing up to $214M if all options are exercised to develop SCY-247 through potential NDA submissions. The base period provides ~$18.5M to advance oral and IV SCY-247 into a Phase 2 invasive candidiasis trial.Material DetailsContext by AI AnalystThis is an ea…